Author Details

Щербина, Анна Юрьевна

Issue	Section	Title	File
Vol 15, No 2 (2018)	Articles	Subcutaneous immunoglobulin for treatment of patients with primary immunodeficiencies: review of the literature and personal experience
Vol 11, No 6 (2014)	Articles	10% INTRAVENOUS IMMUNOGLOBULIN GAMUNEX IN THE TREATMENT OF PRIMARY IMMUNODEFICIENCIES PATIENTS: OWN EXPERIENCE AND LITERATURE REVIEW
Vol 7, No 4 (2010)	Articles	OLYMP programme-basic clinical immunology programme as a part of continued medical education for pediatritiansGeneral aspects of immune response generation. Clinical and laboratory assessment of immune dysfunction
Vol 16, No 4 (2019)	Articles	Х-linked lymphoproliferative syndrome. FEDERAL CLINICAL RECOMMENDATIONS, 2020	(Rus)
Vol 17, No 3 (2020)	Help to the practitioner	Federal clinical guidelines. Primary immunodeficiency: severe combined immunodeficiency	(Rus)
Vol 18, No 3 (2021)	Clinical practice guidelines	Vaccination against COVID-19 for patients with primary immunodeficiency and hereditary angioedema: the position paper of the Russian Association of Allergology, Clinical Immunology, and the National Association of Experts in Primary Immunodeficiencies	(Rus)
Vol 18, No 2 (2021)	Help to the practitioner	Hereditary angioedema. Clinical guidelines. (D84.1)	(Rus)
Vol 20, No 2 (2023)	Original studies	Preliminary results of a non-interventional single-center study evaluating the efficacy of long-term use of lanadelumab in routine clinical practice in the Russian Federation	(Rus) (Eng)